...British researchers have identified specific resistance mutations for ...More than 3% of the world population is infected with HCV which cause... The HCV p7 ion channel plays a critical role in infectious virus prod...In the present study the team set out to expand on their prior work b...

British researchers have identified specific resistance mutations for two classes of p7 inhibitor, which may explain their lack of effectiveness in clinical trials combined with current standard of care. Study results support the role of p7 inhibitor combinations as potential components of future HCV-specific therapies and are available in the July issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

More than 3% of the world population is infected with HCV, which causes severe liver disease. HCV is the leading cause of liver-related mortality and most common cause for liver transplantation in the U.S. Studies have shown that the current treatment of PEGylated interferon alpha (IFN) and ribavirin (Rib) does not adequately achieve a sustained virological response in many HCV patients. This, coupled with the high cost and poor patient compliance, continues to drive demand for new virus-specific therapies.

"The HCV p7 ion channel plays a critical role in infectious virus production, representing an important new therapeutic target," said lead researcher Dr. Stephen Griffin with the Institute of Molecular Medicine at the University of Leeds in the UK. Previously, Dr. Griffin and colleagues determined that p7 acts as a proton channel within HCV infected cells, and that its function could be blocked by small molecule inhibitors, resulting in a blockade of infectious virus production.

In the present study, the team set out to expand on their prior work by predicting inhibitor binding sites using molecular modeling, which were then validated by the identification of resistance mutations. This allowed the researchers to define the mode of action for two prototype p7 inhibitor classesadamantanes (amantadine and rimantadine) and alkylated imino-sugars (IS). This confirmed not only specific, but distinct effects for these inhibitors on the p7 protein. As these '/>"/>

(Date:3/31/2015)... Williams Comfort Air knows people ... their home comfort is at stake. In order ... fit into the customer’s schedule, a new online ... at requested times. , To take advantage ... the Indianapolis area can visit http://williamscomfortair.com/services-maintenance/schedule-online/ , ...

(Date:3/31/2015)... 2015 The Oliver Law Group P.C. ... response to client requests after Zofran lawsuits were filed ... GlaxoSmithKline (GSK) failed to warn physicians and their patients ... medication and “illegally and fraudently” promoted Zofran as a ... approval for that use from the U.S. Food and ...

(Date:3/31/2015)... (PRWEB) March 31, 2015 Rising rates ... have forced researchers and surgeons to better analyze and ... tissues used for repair. A recent study ... a systematic review of 1,016 young, very active patients ... tissues. , “This is the first review to ...

(Date:3/31/2015)... (PRWEB) March 31, 2015 April is Parkinson’s ... is proud to announce 30 Days, 30 Ways to Make ... this month-long campaign that will offer a new action each ... lives of those who battle this disease. , ... that in April alone nearly 5,000 individuals in this country ...

... Association of Urology (EAU) and Europa Uomo, the ... have entered into an,affiliated partnership as part of ... in Europe with regards to urological diseases. Professor ... this unique,EAU affiliated partnership, Europa Uomo will gain ...

... helpings of gravy and dessert at the holiday table are ... thought. According to a new research report recently appearing online ... diet that is high in fat and in sugar actually ... too much fat. This means these foods hit you with ...

... , MINNEAPOLIS, Nov. 30 A new study has found ... a current intention to shop for and possibly switch their Medicare ... Over the past four years, the "intention to switch" measure has ... not everyone with some intention to switch actually will leave their ...

... bills stack up , MONDAY, Nov. 30 (HealthDay News) -- ... differ in a number of ways but achieve the same ... , Legislation approved by the House of Representatives earlier this ... Senate is preparing to debate a proposal to expand coverage ...

(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "European Laboratory Information System ... by Type (Clinical Pathology Laboratory Information System, Anatomic ... report to their offering. The ... grow at a CAGR of 7.6% from 2014 ...

(Date:3/31/2015)... Ajinomoto Althea, Inc. ("Althea"), a leading ... services, announced today that it has added ... growing list of partners in developing and ... Crystalomics ® drug delivery technology. With ... out of 10 of the world,s top ...

... 2011 ChromaDex (OTC Bulletin Board: CDXC ... NUTR ), one of the nation,s largest manufacturers ... pTeroPure™ Pterostilbene in its Solaray® Guaranteed Potency line of ... a product that combines the proven benefits of resveratrol ...

These Iron Control Slides make an excellent addition to your laboratory. Packed ten (10) control slides per box. Use SDL's Snap n' Stain for Iron Staining Kit alongside to save time an money mixing r...

PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....

Microbiology QC Slides come with one or two droplets of an air-dried and methanol-fixed microorganism, or a single smear containing a designated microorganism population....

Each slide contains a high yield of concentrated C. parvum oocysts within the positive control well. A negative control well is also included....